InventisBio Co., Limited (SHA:688382)
China flag China · Delayed Price · Currency is CNY
11.71
-0.68 (-5.49%)
At close: Nov 17, 2026

InventisBio Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
71.0637.29168.79185.53--
Revenue Growth
-60.64%-77.91%-9.02%---
Gross Profit
66.1532.27164.87185.53--
Operating Income
-408.58-351.49-280.95-327.65-519.44-362.8
Net Income
-379.24-316.87-240.2-283.98-483.49-357.91
Earnings Per Share
-0.66-0.55-0.42-0.49-0.95-0.78
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,2341,5351,6871,9192,235724.25
Total Debt
17.4922.0723.9211.6227.3423.66
Net Cash (Debt)
1,2171,5131,6631,9082,208700.6
Net Cash Growth
-19.59%-9.06%-12.82%-13.59%215.14%-32.20%
Net Cash Per Share
2.132.632.913.324.341.53

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-272.87-155.44-241.97-307.75-476.89-252.07
Capital Expenditures
-7.5-6.92-7.56-6.29-7.69-26.52
Free Cash Flow
-280.38-162.36-249.53-314.04-484.59-278.59
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
93.10%86.54%97.67%100.00%--
Operating Margin
-575.00%-942.59%-166.45%-176.61%--
Pretax Margin
-533.66%-849.10%-142.31%-153.06%--
Profit Margin
-533.72%-849.74%-142.31%-153.06%--
FCF Margin
-394.58%-435.41%-147.84%-169.27%--

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
101.07422.4845.4546.92--